BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21762701)

  • 1. Nonlinear viscoelasticity of actin transiently cross-linked with mutant α-actinin-4.
    Yao NY; Becker DJ; Broedersz CP; Depken M; Mackintosh FC; Pollak MR; Weitz DA
    J Mol Biol; 2011 Sep; 411(5):1062-71. PubMed ID: 21762701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.
    Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR
    J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic actin cross-linking governs the cytoplasm's transition to fluid-like behavior.
    Chaubet L; Chaudhary AR; Heris HK; Ehrlicher AJ; Hendricks AG
    Mol Biol Cell; 2020 Jul; 31(16):1744-1752. PubMed ID: 32579489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic cross-linking by alpha-actinin determines the mechanical properties of actin filament networks.
    Xu J; Wirtz D; Pollard TD
    J Biol Chem; 1998 Apr; 273(16):9570-6. PubMed ID: 9545287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin.
    Shao H; Wu C; Wells A
    J Biol Chem; 2010 Jan; 285(4):2591-600. PubMed ID: 19920151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal segmental glomerulosclerosis ACTN4 mutants binding to actin: regulation by phosphomimetic mutations.
    Shao H; Wingert B; Weins A; Pollak MR; Camacho C; Wells A
    Sci Rep; 2019 Oct; 9(1):15517. PubMed ID: 31664084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-actinin binding kinetics modulate cellular dynamics and force generation.
    Ehrlicher AJ; Krishnan R; Guo M; Bidan CM; Weitz DA; Pollak MR
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6619-24. PubMed ID: 25918384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.
    Feng D; Kumar M; Muntel J; Gurley SB; Birrane G; Stillman IE; Ding L; Wang M; Ahmed S; Schlondorff J; Alper SL; Ferrante T; Marquez SL; Ng CF; Novak R; Ingber DE; Steen H; Pollak MR
    J Am Soc Nephrol; 2020 Jul; 31(7):1479-1495. PubMed ID: 32540856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-associated mutant alpha-actinin-4 reveals a mechanism for regulating its F-actin-binding affinity.
    Weins A; Schlondorff JS; Nakamura F; Denker BM; Hartwig JH; Stossel TP; Pollak MR
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16080-5. PubMed ID: 17901210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.
    Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY
    J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors.
    Khurana S; Chakraborty S; Lam M; Liu Y; Su YT; Zhao X; Saleem MA; Mathieson PW; Bruggeman LA; Kao HY
    J Biol Chem; 2012 Apr; 287(15):12027-35. PubMed ID: 22351778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-layered proteomic characterization of a novel ACTN4 mutation unravels its pathogenic potential in FSGS.
    Bartram MP; Habbig S; Pahmeyer C; Höhne M; Weber LT; Thiele H; Altmüller J; Kottoor N; Wenzel A; Krueger M; Schermer B; Benzing T; Rinschen MM; Beck BB
    Hum Mol Genet; 2016 Mar; 25(6):1152-64. PubMed ID: 26740551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the assembly of the multiple domains of α-actinin-4 and its role in actin cross-linking.
    Travers T; Shao H; Wells A; Camacho CJ
    Biophys J; 2013 Feb; 104(3):705-15. PubMed ID: 23442921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Regulation of α-Actinin's Calponin Homology Domains on F-Actin.
    Shams H; Golji J; Garakani K; Mofrad MR
    Biophys J; 2016 Mar; 110(6):1444-55. PubMed ID: 27028653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viscoelastic properties of F-actin solutions in the presence of normal and mutated actin-binding proteins.
    Janssen KP; Eichinger L; Janmey PA; Noegel AA; Schliwa M; Witke W; Schleicher M
    Arch Biochem Biophys; 1996 Jan; 325(2):183-9. PubMed ID: 8561496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel splicing isoform of actin-binding protein alpha-actinin 4 in epidermoid carcinoma cells A431].
    Aksenova VIu; Khotin MG; Turoverova LV; Iudintseva NM; Magnusson KÉ; Pinaev GP; Tentler DG
    Tsitologiia; 2012; 54(1):25-32. PubMed ID: 22567897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-causing mutation in α-actinin-4 promotes podocyte detachment through maladaptation to periodic stretch.
    Feng D; Notbohm J; Benjamin A; He S; Wang M; Ang LH; Bantawa M; Bouzid M; Del Gado E; Krishnan R; Pollak MR
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1517-1522. PubMed ID: 29378953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein.
    Yao J; Le TC; Kos CH; Henderson JM; Allen PG; Denker BM; Pollak MR
    PLoS Biol; 2004 Jun; 2(6):e167. PubMed ID: 15208719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.
    Kaplan JM; Kim SH; North KN; Rennke H; Correia LA; Tong HQ; Mathis BJ; Rodríguez-Pérez JC; Allen PG; Beggs AH; Pollak MR
    Nat Genet; 2000 Mar; 24(3):251-6. PubMed ID: 10700177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice with podocyte-specific overexpression of wild type alpha-actinin-4 are healthy controls for K256E-alpha-actinin-4 mutant transgenic mice.
    Michaud JL; Stitt-Cavanaugh E; Endlich N; Endlich K; De Repentigny Y; Kothary R; Kennedy CR
    Transgenic Res; 2010 Apr; 19(2):285-9. PubMed ID: 19585264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.